[1] Abbas Z, Yakoob J, Usman MW, et al. Effect of helicobacter pylori and its virulence factors on portal hypertensive gastropathy and interleukin (IL)-8, IL-10,tumor necrosis factor-alpha levels[J]. Saudi J Gastroenterol.2014 Mar-Apr;20(2):120-127.
[2] Tsui CP, Sung JJ, Leung FW.Role of acute elevation of portal venous pressure by exogenous glucagon on gastric mucosal injury in rats with portal hypertension[J]. Life Sci,2003,73(9):1115-1129.
[3] Curvêlo LA, Brabosa W, Rhor R, et al.Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach[J]. J Gastroenterol Hepatol,2009,24(9):1541-1546.
[4] Sathar SA, Kunnathuparambil SG, Sreesh S, et al.Helicobacter pylori infection in patients with liver cirrhosis: prevalence and association with portal hypertensive gastropathy[J]. Ann Gastroenterol,2014,27(1):48-52.
[5] de Lisi S, Peralta S, Arini A, et al. Oesophagogastroduodenoscopy in patients with cirrhosis: Extending the range of detection beyond portal hypertension[J]. Dig Liver Dis,2011,43(1):48-53.
[6] Primignani M, Carpinelli L, Preatoni P, et al.Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC)[J]. Gastroenterology,2000,119(1):181-187.
[7] Karki L, Gorkhaly MP, Karki BB.Study of upper gastrointestinal tract endoscopic findings in portal hypertension[J]. J Nepal Med Assoc,2013,52(190):337-342.
[8] Gjeorgjievski M, Cappell MS.Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy[J]. World J Hepatol,2016,8(4):231-262.
[9] Cubillas R, Rockey DC.Portal hypertensive gastropathy: a review[J]. Liver Int,2010,30(8):1094-1102.
[10] Elwakil R, Al Breedy AM, Gabal HH. Effect of endoscopic variceal obliteration by band ligation on portal hypertensive gastro-duodenopathy: endoscopic and pathological study[J/OL]. Hepatol Int,2016-03-01[2016-09-18].https://www.ncbi.nlm.nih.gov/pubmed/26932843.
[11] Fontana RJ, Sanyal AJ, Mehta S, et al.Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial[J]. Am J Gastroenterol,2006,101(5):983-992.
[12] Kimura K, Ikegami T, Bekki Y, et al.Clinical significance of gastrointestinal bleeding after living donor liver transplantation[J]. Transpl Int,2014,27(7):705-711.
[13] Baran B.Nucleos(t)ide analogs in the prevention of hepa-titis B virus related hepatocellular carcinoma[J]. World J Hepatol,2015,7(13):1742-1754.
[14] Kim TU, Kim S, Woo SK, et al.Dynamic CT of portal hypertensive gastropathy: significance of transient gastric perfusion defect sign[J]. Clin Radiol,2008,63(7):783-790.
[15] Spina GP, Arcidiacono R, Bosch J, et al.Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992[J]. J Hepatol,1994,21(3):461-467.
[16] Tanoue K, Hashizume M, Wada H, et al.Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study[J]. Gastrointest Endosc,1992, 38(5):582-585.
[17] Pérez-Ayuso RM, Piqué JM, Bosch J, et al.Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis[J]. Lancet,1991,337(8755):1431-1434.
[18] 顾星石, 白旭明, 程龙, 等. 经颈静脉肝内门体静脉分流术治疗肝硬化上消化道出血的中远期疗效观察[J]. 内科理论与实践,2015,(4):266-271.
[19] Ripoll C, Garcia-Tsao G.Management of gastropathy and gastric vascular ectasia in portal hypertension[J]. Clin Liver Dis,2010,14(2):281-295.
[20] Zhou Y, Qiao L, Wu J, et al.Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study[J]. J Gastroenterol Hepatol,2002,17(9):973-979.
[21] Bruha R, Marecek Z, Spicak J, et al.Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding[J]. Hepatogastroenterology,2002,49(46):1161-1166.
[22] Herrera S, Bordas JM, Llach J, et al.The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage[J]. Gastrointest Endosc,2008,68(3):440-446.
[23] Lo GH.The use of transjugular intrahepatic portosystemic stent shunt (TIPS) in the management of portal hypertensive bleeding[J]. J Chin Med Assoc,2014,77(8):395-402.
[24] Biecker E.Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management[J]. World J Gastroenterol,2013,19(31):5035-5050.
[25] Cremers I, Ribeiro S.Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis[J]. Therap Adv Gastroenterol,2014,7(5):206-216.
[26] Snyder P, Ali R, Poles M, et al.Portal hypertensive gastropathy with a focus on management[J]. Expert Rev Gastroenterol Hepatol,2015,9(9):1207-1216.
[27] Chung WJ.Management of portal hypertensive gastropathy and other bleeding[J]. Clin Mol Hepatol,2014,20(1):1-5.
[28] Bhardwaj A, Kedarisetty CK, Vashishtha C, et al. Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial[J/OL]. Gut,2016-06-13[2016-09-18].https://www.ncbi.nlm.nih.gov/pubmed/27298379. |
